Summary of COVID-19 nicotine studies
Hide extended summaries
RCT 218 critically ill COVID-19 patients showing no benefit of transdermal nicotine patches. The trial tested a hypothesis that emerged early in the pandemic based on observations of lower COVID-19 rates among smokers, however alternative explanations such as nitric oxide generation in the respiratory tract may be more likely.
Jun 2022, Intensive Care Medicine, https://link.springer.com/10.1007/s00134-022-06721-1, https://c19p.org/labro
1. Labro et al., Nicotine patches in patients on mechanical ventilation for severe COVID-19: a randomized, double-blind, placebo-controlled, multicentre trial
218 patient nicotine late treatment RCT: 5% higher mortality (p=0.78) and 6% higher progression (p=1).RCT 218 critically ill COVID-19 patients showing no benefit of transdermal nicotine patches. The trial tested a hypothesis that emerged early in the pandemic based on observations of lower COVID-19 rates among smokers, however alternative explanations such as nitric oxide generation in the respiratory tract may be more likely.
Jun 2022, Intensive Care Medicine, https://link.springer.com/10.1007/s00134-022-06721-1, https://c19p.org/labro
Please send us corrections, updates, or comments.
c19early involves the extraction of 100,000+ datapoints from
thousands of papers. Community updates
help ensure high accuracy.
Treatments and other interventions are complementary.
All practical, effective, and safe
means should be used based on risk/benefit analysis.
No treatment or intervention is 100% available and effective for all current
and future variants.
We do not provide medical advice. Before taking any medication,
consult a qualified physician who can provide personalized advice and details
of risks and benefits based on your medical history and situation. IMA and WCH
provide treatment protocols.
Thanks for your feedback! Please search before submitting papers and note
that studies are listed under the date they were first available, which may be
the date of an earlier preprint.